Cognition Therapeutics, Inc. Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (5 lists). Names and jurisdictions are as filed.
- 2026-03-26: Subsidiary None..
- 2025-03-20: Subsidiary None..
- 2024-03-26: Subsidiary Cognition Therapeutics PTY LTD; Jurisdiction Australia.
- 2023-03-23: Subsidiary Cognition Therapeutics PTY LTD; Jurisdiction Australia.
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2026-03-26 | None. | |
| 2025-03-20 | None. | |
| 2024-03-26 | Cognition Therapeutics PTY LTD | Australia |
| 2023-03-23 | Cognition Therapeutics PTY LTD | Australia |
| 2022-03-30 | Cognition Therapeutics PTY LTD | Australia |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |